Publications by authors named "Tim B Fessenden"

Claim this Profile
D
Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins.
Tim B Fessenden, Lauren E Stopfer, Fiona Chatterjee, Julian Zulueta, Josh Mesfin

J Immunother Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type I interferon activates MHC class I-dressed CD11b conventional dendritic cells to promote protective anti-tumor CD8 T cell immunity.
Ellen Duong, Tim B Fessenden, Emi Lutz, Teresa Dinter, Leon Yim

Immunity· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue Site and the Cancer Immunity Cycle.
Brendan L Horton, Tim B Fessenden, Stefani Spranger

Trends Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dia1-dependent adhesions are required by epithelial tissues to initiate invasion.
Tim B Fessenden, Yvonne Beckham, Mathew Perez-Neut, Guillermina Ramirez-San Juan, Aparajita H Chourasia

J Cell Biol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer.
Steven Kregel, James L Chen, Westin Tom, Venkatesh Krishnan, Jacob Kach, Tim B Fessenden

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes.
Colleen A Fordyce, Kelley T Patten, Tim B Fessenden, RosaAnna DeFilippis, E Shelley Hwang

Breast Cancer Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis